Clinical trialPhase 1Completed
Ultrasound-assisted Treatment of Inoperable Pancreatic Cancer
Treatment of Pancreatic Adenocarcinoma by Combining Contrast Agent and Gemitabine Under Sonification
- Outcome
- Finished, no results posted
- Phase
- Phase 1
- Status
- Completed
- Study type
- Interventional
- Start
- February 2012
- Expected end
- January 2015
- Enrollment
- 25 participants
- Sites
- 1
- Primary outcomes
- Toxic effects and safety of gemcitabine in combination with US contrast agent under sonication with gemcitabine alone.
- Sponsor
- Other
- Results posted
- No
- Last update
- 24 September 2015
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try